
Optimized workflow and robust QC ensures similar viral (IFU) and functional titers (TU)

Viral Titer (108)
Superior Transduction Performance
One Stop Shop
High Titer
96%
Success rate
20,000+
Successful LVV projects delivered
20+
Proprietary lentiviral vectors
Titer(TU/mL) | Volume | QC | Application | Turnaround Time | Pricing |
---|---|---|---|---|---|
Regular Titer(>107) | 1000 µL |
Default:
Additional fee for:
|
Cell Culture | 2-3 weeks | Get A Quote |
2000 µL | |||||
5000 µL | 3-4 weeks | ||||
10000 µL | |||||
High Titer(>108) | 1000 µL | 2-3 weeks | |||
2000 µL | |||||
5000 µL | 3-4 weeks | ||||
10000 µL | |||||
Ultra-High(>109) | 100 µL | 2-3 weeks | |||
200 µL |
Note:
We provide lentiviral particles at highly customizable titers and volumes. We also provide non-integrating
lentivirus please email us for more information.
For GMP grade lentivirus packaging services please
click
here
for
more information.
Optimized workflow and robust QC ensures similar viral (IFU) and functional titers (TU)
Viral Titer (108)
Add-On Service | Description | |
---|---|---|
1 | FACS analysis | Validate the transgene expression by FACS analysis. A validated antibody with specific binding to target protein or reporter tag must be provided. |
2 | Sanger Sequencing | Validate the integrity of inserted gene of interest (GOI). |
Application | Vector Name | Insert Capacity (bp) | Promoter | Linker | Antibiotics Marker | Fluorescence Marker |
---|---|---|---|---|---|---|
GS proprietary lentiviral vector with antibiotic marker only | ||||||
Constitutive Overexpression | GLV2-CAG-[ORF]-PGK-Puro | 4273 | CAG | / | Puro | / |
GLV2-CAG-[ORF]-PGK-BSD | 4474 | CAG | / | BSD | / | |
GLV2-CMV-[ORF]-PGK-BSD | 4620 | CMV | / | BSD | / | |
GLV2-CMV-[ORF]-PGK-Hyg | 3993 | CMV | / | Hygro | / | |
GLV2-CMV-[ORF]-PGK-Neo | 4224 | CMV | / | Neo | / | |
GLV2-CMV-[ORF]-PGK-Puro | 4419 | CMV | / | Puro | / | |
GLV2-EF1a-[ORF]-PGK-Hyg | 3261 | EF1a | / | Hygro | / | |
GLV2-EF1a-[ORF]-PGK-Neo | 3492 | EF1a | / | Neo | / | |
GLV2-EF1a-[ORF]-PGK-Puro | 3687 | EF1a | / | Puro | / | |
GLV2-EF1a-[ORF]-PGK-BSD | 3888 | EF1a | / | BSD | / | |
GS proprietary lentiviral vector with antibiotic marker & fluorescent tag | ||||||
Constitutive Overexpression | GLV2-CAG-[ORF]-PGK-BSD-P2A-EGFP | 3691 | CAG | P2A | BSD | EGFP |
GLV2-CAG-[ORF]-PGK-Puro-P2A-EGFP | 3490 | CAG | P2A | Puro | EGFP | |
GLV2-CAG-[ORF]-PGK-Puro-P2A-mCherry | 3493 | CAG | P2A | Puro | mCherry | |
GLV2-CAG-[ORF]-PGK-BSD-P2A-mCherry | 3694 | CAG | P2A | BSD | mCherry | |
GLV2-CMV-[ORF]-PGK-BSD-P2A-EGFP | 3601 | CMV | P2A | BSD | EGFP | |
GLV2-CMV-[ORF]-PGK-Puro-P2A-EGFP | 3400 | CMV | P2A | Puro | EGFP | |
GLV2-CMV-[ORF]-PGK-BSD-P2A-mCherry | 3604 | CMV | P2A | BSD | mCherry | |
GLV2-CMV-[ORF]-PGK-Puro-P2A-mCherry | 3403 | CMV | P2A | Puro | mCherry | |
GLV2-EF1a-[ORF]-PGK-BSD-P2A-EGFP | 3094 | EF1a | P2A | BSD | EGFP | |
GLV2-EF1a-[ORF]-PGK-BSD-P2A-mCherry | 3099 | EF1a | P2A | BSD | mCherry | |
GLV2-EF1a-[ORF]-PGK-Puro-P2A-EGFP | 2904 | EF1a | P2A | Puro | EGFP | |
GLV2-EF1a-[ORF]-PGK-Puro-P2A-mCherry | 2898 | EF1a | P2A | Puro | mCherry | |
IP free lentiviral vector | ||||||
Constitutive Overexpression | pGenlenti-CMV-[ORF]-IRES-Puro | 3864 | CMV | IRES | Puro | / |
Transfer plasmid for CRISPR system | ||||||
CRISPR System | pLentiCRISPRv2-U6-[gRNA]-EFS-Cas9-P2A-Puro | 836 | U6 | P2A | Puro | / |
pLentiGuide-U6-[gRNA]-EF1a-Puro | 4178 | U6 | / | Puro | / | |
2nd generation transfer plasmid | ||||||
Constitutive Overexpression | pLVX-CMV-[ORF]-PGK-Puro | 3549 | CMV | / | Puro | / |
pLVX-EF1a-[ORF]-PGK-BSD | 3058 | EF1a | / | BSD | / | |
Inducible Expression | pLVX-Tet-On3G-PGK-Neo | 2611 | CMV | / | Neo | / |
pLVX-TRE3GV-[ORF]-PGK-Puro | 3824 | TRE3G | / | Puro | / |
Lentivirus transduction test
Target cell: 293T Titer: 7.8*108 TU/mL Time: 72 hours after transduction MOI: 20
Cell Line | Name | MOI |
---|---|---|
CT26 | Mouse colony | 100 |
BAF3 | Mouse B cell | |
EL4 | Mouse T lymphoma | |
RAW 246.7 | Monocyle/macrophage-like cells | |
Jurkat | Human acute T cell Leukemia | |
K562 | Meylogenous leukemia cell line | |
NALM6 | B cell precursor leukemia cell | |
THP-1 | Acute monocytic leukemia |
GenScript offers proprietray lentiviral packaging platform to ensure you getting functional intact virus everytime.
Learn MoreThe Valuable Guide for Your Cell Engineering Research.
Free Download